REYON Pharmaceutical Co., Ltd. (KRX: 102460)

REYON Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	234,031	303,360	384,347	631,111	390,433	264,446
Market Cap Growth	-12.70%	-21.07%	-39.10%	61.64%	47.64%	15.07%
Enterprise Value	380,086	498,164	550,681	726,725	401,156	228,088
Last Close Price	12760.00	16540.00	21446.14	34975.15	21584.40	15173.35
PE Ratio	380.05	84.66	52.23	116.61	101.56	53.46
PS Ratio	1.56	2.01	2.50	4.42	3.00	2.01
PB Ratio	0.95	1.22	1.55	2.57	1.70	1.19
P/TBV Ratio	1.03	1.23	1.56	2.59	1.71	1.22
P/OCF Ratio	68.26	35.09	44.03	54.01	84.89	-
EV/Sales Ratio	2.54	3.30	3.57	5.09	3.09	1.73
EV/EBITDA Ratio	56.81	76.00	61.31	117.02	64.51	21.30
EV/EBIT Ratio	147.88	281.00	123.80	470.45	242.52	34.44
EV/FCF Ratio	-19.38	-	-	-	-	-
Debt / Equity Ratio	0.62	0.91	0.85	0.85	0.26	0.15
Debt / EBITDA Ratio	18.67	34.33	23.40	33.38	9.56	3.14
Asset Turnover	0.30	0.31	0.32	0.36	0.44	0.46
Inventory Turnover	2.23	2.25	2.60	2.35	2.22	2.59
Quick Ratio	0.34	0.51	1.63	2.91	1.83	3.21
Current Ratio	0.63	0.79	2.27	3.47	2.42	3.94
Return on Equity (ROE)	0.25%	1.44%	3.02%	2.33%	1.70%	2.21%
Return on Assets (ROA)	0.51%	0.23%	0.58%	0.24%	0.35%	1.44%
Return on Capital (ROIC)	0.58%	0.24%	0.61%	0.26%	0.38%	1.61%
Earnings Yield	0.26%	1.18%	1.93%	0.88%	0.98%	1.87%
FCF Yield	-8.38%	-6.67%	-14.15%	-16.68%	-12.22%	-23.87%
Dividend Yield	1.18%	0.91%	0.70%	0.71%	0.93%	2.26%
Payout Ratio	446.76%	76.41%	61.39%	62.56%	150.47%	167.08%
Buyback Yield / Dilution	1.91%	-0.46%	-3.03%	-4.05%	-1.01%	0.80%
Total Shareholder Return	3.08%	0.44%	-2.33%	-3.34%	-0.09%	3.07%

Source: S&P Capital IQ. Standard template. Financial Sources.